740 Y-P

C([C@@H](C(N[C@@H](CC1=CC=CC=C1)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC=2C=3C(NC2)=CC=CC3)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(NCC(N[C@@H](CC4=CC=C(OP(=O)(O)O)C=C4)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CO)=O)CCSC)=O)CC(O)=O)=O)CCSC)=O)=O)=O)=O)CC(O)=O)=O)CO)=O)CCCCN)=O)CCCCN)=O)=O)CCCCN)=O)CCSC)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CC(N)=O)=O)CCC(N)=O)=O)=O)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CCCNC(=N)N)N)=O)CCC(N)=O)=O)[C@H](CC)C)=O)CCCCN)=O)[C@H](CC)C)=O)C=5C=6C(NC5)=CC=CC6

[1]Derossi D, et al. Stimulation of mitogenesis by a cell-permeable PI 3-kinase binding peptide.|[2]Xiaoli Feng, et al. Graphene Oxide Induces p62/SQSTM-dependent Apoptosis Through the Impairment of Autophagic Flux and Lysosomal Dysfunction in PC12 Cells. Acta Biomater. 2018 Nov;81:278-292.|[3]Zhiqing Sun, et al. GABAB Receptor-Mediated PI3K/Akt Signaling Pathway Alleviates Oxidative Stress and Neuronal Cell Injury in a Rat Model of Alzheimer's Disease. J Alzheimers Dis. 2020;76 (4) :1513-1526.

ACS Omega. 2022 Nov 16;7 (47) :42723-42732.|Acta Biomater. 2018 Nov:81:278-292.|Adv Sci (Weinh) . 2025 Apr;12 (13) :e2410032.|Aging (Albany NY) . 2021 Sep 27;13 (18) :22502-22515.|Am J Transl Res. 2021 Apr 15;13 (4) :2060-2076.|Am J Transl Res. 2025 Mar 15;17 (3) :2145-2153.|Ann N Y Acad Sci. 2025 Nov 24.|Apoptosis. 2024 Aug;29 (7-8) :1185-1197.|Apoptosis. 2025 Feb;30 (1-2) :16-34.|Arch Biochem Biophys. 2023 Jul 15:743:109645.|Arch Dermatol Res. 2024 Dec 5;317 (1) :70.|Arch Pharm Res. 2021 Feb;44 (2) :194-204.|Biochem Biophys Res Commun. 2022 May 21;605:162-170.|Biochem Biophys Res Commun. 2023 Sep 3:671:246-254.|Biochem Biophys Res Commun. 2024 Apr 23:149983.|Biochem Biophys Res Commun. 2025 May 16:771:152037.|Biochem Biophys Res Commun. 2025 Sep 8:778:152337.|Biochem Pharmacol. 2024 Nov 9:116620.|Biochem Pharmacol. 2025 Dec;242 (Pt 3) :117405.|Bioengineered. 2021 Dec;12 (2) :12940-12953.|Bioengineered. 2022 Apr;13 (4) :10047-10060.|Biol Reprod. 2023 Nov 15;109 (5) :736-748.|Biomater Adv. 2026 Mar:180:214576.|Biomaterials. 2019 Feb;194:57-72. |Biomed Pharmacother. 2020 Nov;131:110689.|Biomed Pharmacother. 2024 Nov:180:117560.|Bioorg Chem. 2025 Sep 16:165:109002.|Bioresour Bioprocess. 2025 Jul 30;12 (1) :82.|bioRxiv. 2023 Mar 25:2023.03.23.534007.|bioRxiv. 2025 Mar 26:2025.03.24.645017.|BMC Cancer. 2022 Jun 18;22 (1) :671.|BMC Cancer. 2023 Jul 5;23 (1) :628.|BMC Med. 2022 Dec 8;20 (1) :475.|Bone Joint Res. 2025 Feb 6;14 (2) :97-110.|Braz J Med Biol Res. 2024 Aug 19:57:e13796.|Braz J Med Biol Res. 2025 Mar 24:58:e14408.|Cancer Med. 2023 Mar;12 (5) :5781-5797.|Cancer Rep (Hoboken) . 2025 May;8 (5) :e70220.|Cancers (Basel) . 2023 Mar 28;15 (7) :2023.|Cancers (Basel) . 2025 Aug 29;17 (17) :2846.|Carbon. 2023 Jan 25, 217, 118617.|Cell Biochem Biophys. 2025 Jun;83 (2) :1785-1798.|Cell Biochem Biophys. 2025 Jun;83 (2) :2023-2033.|Cell Biol Toxicol. 2025 Jul 1;41 (1) :110.|Cell Biosci. 2019 Aug 27;9:68.|Cell Commun Signal. 2020 Aug 24;18 (1) :131.|Cell Death Dis. 2021 Sep 13;12 (9) :845.|Cell Death Dis. 2025 Jun 16;16 (1) :451.|Cell Mol Life Sci. 2024 Mar 13;81 (1) :133.|Cell Prolif. 2022 Sep 26; e13342.|Cell Rep. 2021 Nov 16;37 (7) :110007.|Cell Signal. 2020 Jul;71:109606.|Cell Signal. 2025 Nov:135:111984.|Cell Signal. 2025 Nov:135:112026.|Cells. 2023 Jan 3;12 (1) :194.|Chin Med. 2022 Sep 29;17 (1) :115.|Clin Med Insights Oncol. 2021 May 5:15:11795549211012666.|Contrast Media Mol Imaging. 2022 Jul 14:2022:2109908.|Curr Eye Res. 2025 Jun 24:1-9.|Curr Med Sci. 2025 Apr;45 (2) :253-263.|Curr Med Sci. 2025 Oct 16.|Curr Microbiol. 2025 Feb 3;82 (3) :110.|Cytokine. 2022 Feb:150:155776.|Cytotechnology. 2025 Apr;77 (2) :77.|Dis Markers. 2021 Sep 1:2021:9950663.|Discov Oncol. 2025 Sep 30;16 (1) :1789.|Drug Dev Res. 2022 Aug;83 (5) :1152-1166.|Drug Dev Res. 2022 Nov;83 (7) :1673-1682.|Drug Resist Updat. 2024 Dec 3:78:101179.|Electron J Biotechnol. 2025 Aug 13.|Epigenetics. 2023 Dec;18 (1) :2239607.|Eur J Histochem. 2025 Jun 17;69 (3) .|Eur J Pharmacol. 2023 Sep 5:954:175863.|Eur J Pharmacol. 2024 Apr 5:968:176401.|Eur J Pharmacol. 2024 Sep 10:176824.|Eur J Pharmacol. 2024 Sep 10:176991.|Exp Cell Res. 2019 Dec 15;385 (2) :111691.|Exp Eye Res. 2023 Jan:226:109335.|Exp Mol Med. 2023 May;55 (5) :939-951.|Exp Ther Med. 2021 Sep;22 (3) :1017.|Fish Shellfish Immunol. 2022 Jan:120:648-657.|Folia Neuropathol. 2025 Apr 4.|Food Chem Toxicol. 2025 Oct:204:115664.|Free Radic Biol Med. 2023 Oct 10;209 (Pt 1) :55-69.|Front Biosci (Landmark Ed) . 2024 Aug 19;29 (8) :289.|Front Pharmacol. 2020 Feb 25;11:114. |Front Pharmacol. 2021 Jul 15:12:667644.|Gene Ther. 2024 Nov;31 (11-12) :594-606.|Genes (Basel) . 2023 Apr 20;14 (4) :944.|Genes Dis. 2021 Jul 1;9 (6) :1650-1661.|Genome Med. 2025 Sep 25;17 (1) :102.|Genomics. 2023 Jul;115 (4) :110636.|Glia. 2023 Mar;71 (3) :720-741.|Heliyon. 2024 Aug 20;10 (17) :e36579.|Heliyon. 2024 Jul 10;10 (14) :e34397.|Heliyon. 2024 Jun 10;10 (12) :e32802.|Heliyon. 2024 May 31;10 (11) :e32230.|In Vitro Cell Dev Biol Anim. 2022 Jun;58 (6) :491-502.|Inflammopharmacology. 2023 Feb;31 (1) :369-384.|Int Immunopharmacol. 2023 Sep 5;124 (Pt A) :110876.|Int Immunopharmacol. 2023 Sep:122:110579.|Int Immunopharmacol. 2024 Jul 26:139:112717.|Int Immunopharmacol. 2024 May 17:134:112241.|Int Immunopharmacol. 2024 May 30:133:112005.|Int Immunopharmacol. 2025 Apr 4:151:114352.|Int Immunopharmacol. 2025 Aug 3:163:115304.|Int J Biol Macromol. 2023 Jul 31:244:125373.|Int J Biol Macromol. 2024 Sep 10:135547.|Int J Biol Macromol. 2025 Jan 10:139766.|Int J Biol Sci. 2025 Aug 11;21 (12) :5206-5222.|Int J Gen Med. 2025 Sep 19:18:5699-5716.|Int J Mol Med. 2021 Feb;47 (2) :688-698.|Int J Mol Med. 2021 May;47 (5) :67.|Int J Mol Med. 2023 May;51 (5) :40.|Int J Mol Med. 2025 Nov;56 (5) :194.|Int J Mol Sci. 2023 May 19;24 (10) :9000.|Int J Mol Sci. 2024 Dec 25;26 (1) :84.|Int J Oncol. 2021 Jul;59 (1) :42.|Int J Oncol. 2021 May;58 (5) :23.|Ir J Med Sci. 2023 Apr;192 (2) :561-567.|iScience. 2024 Jan 17;27 (2) :108926.|J Agric Food Chem. 2022 Dec 21;70 (50) :15804-15817.|J Agric Food Chem. 2025 May 14;73 (19) :11730-11755.|J Biochem Mol Toxicol. 2025 Apr;39 (4) :e70210.|J Cell Mol Med. 2024 Jul;28 (13) :e18386.|J Cell Physiol. 2024 Jun;239 (6) :e31259.|J Clin Invest. 2023 Jan 17;133 (2) :e153470.|J Clin Lab Anal. 2022 Dec;36 (12) :e24720.|J Colloid Interface Sci. 2025 Oct 8;703 (Pt 2) :139206.|J Control Release. 2025 Oct 22;388 (Pt 2) :114350.|J Dairy Sci. 2022 Apr;105 (4) :3405-3415.|J Ethnopharmacol. 2021 Dec 5:281:114438.|J Ethnopharmacol. 2024 Mar 25:322:117628.|J Ethnopharmacol. 2024 May 10:325:117768.|J Ethnopharmacol. 2025 Jan 18:119381.|J Ethnopharmacol. 2025 Jan 30;337 (Pt 2) :118910.|J Exp Clin Cancer Res. 2020 Jun 30;39 (1) :123.|J Exp Clin Cancer Res. 2021 Aug 12;40 (1) :255.|J Funct Foods. 2023 Oct, 109, 105770.|J Gastroenterol Hepatol. 2025 Aug;40 (8) :1991-2006.|J Headache Pain. 2022 Aug 10;23 (1) :98.|J Hepatocell Carcinoma. 2021 Nov 3;8:1323-1338.|J Inflamm Res. 2025 Aug 3:18:10389-10402.|J Integr Med. 2025 Sep 4:S2095-4964 (25) 00137-2.|J Mol Histol. 2023 Dec;54 (6) :621-631.|J Nutr Biochem. 2022 Feb:100:108882.|J Nutr Biochem. 2024 Jul 16:109702.|J Pharm Pharmacol. 2022 Sep 1;74 (9) :1251-1260.|J Steroid Biochem Mol Biol. 2025 Jul 3:254:106825.|J Transl Med. 2021 Feb 10;19 (1) :62.|J Transl Med. 2023 Nov 16;21 (1) :817.|J Transl Med. 2024 Nov 29;22 (1) :1085.|Kaohsiung J Med Sci. 2025 Nov 5:e70131.|Korean J Physiol Pharmacol. 2022 Nov 1;26 (6) :541-556.|Life Sci. 2019 Sep 15:233:116696.|Life Sci. 2021 Nov 1:284:119107.|Mater Today Bio. 2022 Jul 1;16:100344.|Mol Biol Rep. 2023 Jan;50 (1) :687-696.|Mol Cancer. 2022 May 10;21 (1) :112.|Mol Cell Biochem. 2022 Jul;477 (7) :1947-1957.|Mol Cell Biochem. 2022 May;477 (5) :1541-1553.|Mol Cell Proteomics. 2023 Sep;22 (9) :100628.|Mol Cell. 2025 Apr 3;85 (7) :1411-1425.e8.|Mol Immunol. 2025 Sep:185:27-38.|Mol Med Rep. 2021 Jan;23 (1) :76.|Mol Med. 2023 Oct 3;29 (1) :133.|Mol Neurobiol. 2025 Mar;62 (3) :3615-3629.|Nat Commun. 2024 Sep 12;15 (1) :7996.|Naunyn Schmiedebergs Arch Pharmacol. 2024 Feb;397 (2) :1003-1013.|Neurogastroenterol Motil. 2020 Oct;32 (10) :1514-1528.|Neuropharmacology. 2025 Nov 15:279:110631.|Noncoding RNA Res. 2024 Nov 12.|Onco Targets Ther. 2019 Dec 4;12:10639-10650.|Oncol Lett. 2021 Dec;22 (6) :812.|Oncol Lett. 2023 Apr 13;25 (6) :224.|Oncol Lett. 2023 Nov 15;27 (1) :17.|Oncol Rep. 2020 Mar;43 (3) :919-929.|Oncol Rep. 2021 May;45 (5) :63.|Oncol Rep. 2022 Oct;48 (4) :169.|OncoTargets and Therapy Dovepress. 2019 Oct 16;12:8537-8552.|Oral Dis. 2024 Oct;30 (7) :4231-4242.|Oxid Med Cell Longev. 2021 Mar 30:2021:6661534.|Pathol Res Pract. 2023 Sep:249:154717.|Pharm Biol. 2022 Dec;60 (1) :75-86.|Pharmaceuticals (Basel) . 2025 Sep 16;18 (9) :1378.|Phytomedicine. 2022 May:99:154014.|Phytomedicine. 2022 Oct:105:154360.|Phytomedicine. 2023 Dec:121:155117.|Phytomedicine. 2023 Jul 25:116:154873.|Phytomedicine. 2025 May:140:156498.|Phytother Res. 2023 Aug;37 (8) :3572-3582.|Phytother Res. 2024 Jul;38 (7) :3509-3524.|PLoS One. 2024 Oct 16;19 (10) :e0311419.|PLoS One. 2024 Sep 27;19 (9) :e0311143.|Research Square Preprint. 2023 Apr 13.|Research Square Preprint. 2023 Aug 10.|Research Square Preprint. 2024 Mar 25.|Research Square Preprint. 2024 May 2.|Research Square Print. 2022 May.|Respir Physiol Neurobiol. 2020 Oct;281:103496.|Sci Rep. 2021 Sep 29;11 (1) :19268.|Sci Rep. 2023 Jul 21;13 (1) :11795.|Sci Rep. 2024 Aug 30;14 (1) :20231.|Sci Rep. 2024 Sep 5;14 (1) :20802.|Sci Rep. 2025 Apr 19;15 (1) :13539.|Sci Rep. 2025 Mar 20;15 (1) :9644.|Sci Rep. 2025 Mar 4;15 (1) :7639.|Sci Rep. 2025 May 9;15 (1) :16205.|SSRN. 2025 Sep 19.|Technol Cancer Res Treat. 2020 Jan-Dec:19:1533033820957023.|Theranostics. 2024 Jul 8;14 (11) :4278-4296.|Toxicol Appl Pharmacol. 2020 Dec 15;409:115335.|Toxicol Appl Pharmacol. 2022 Apr 15:441:115971.|Toxicol In Vitro. 2022 Apr;80:105328.|Tradit Med Res. 2020 May.|Viruses. 2023 Jul 28;15 (8) :1646.|World J Gastrointest Oncol. 2023 Oct 15;15 (10) :1739-1755.|BMC Complement Med Ther. 2023 Aug 22;23 (1) :295.